Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.

Bruland O, Fluge Ø, Akslen LA, Eiken HG, Lillehaug JR, Varhaug JE, Knappskog PM.

BMC Cancer. 2009 Dec 8;9:425. doi: 10.1186/1471-2407-9-425.

2.

Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.

Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.

J Pathol. 2007 Oct;213(2):190-9.

PMID:
17703498
3.

Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.

Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y, Uchida K.

Clin Cancer Res. 2004 Mar 15;10(6):2035-43.

4.

Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.

Uutela M, Laurén J, Bergsten E, Li X, Horelli-Kuitunen N, Eriksson U, Alitalo K.

Circulation. 2001 May 8;103(18):2242-7.

5.

Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.

Ulivieri A, Lavra L, Dominici R, Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis T, Jia-Jing L, Larsson C, Bartolazzi A, Sciacchitano S.

J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.

PMID:
18306168
7.

Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes.

Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C.

J Clin Oncol. 2004 Sep 1;22(17):3531-9.

PMID:
15337802
8.

Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B.

Cancer Res. 2004 Jun 1;64(11):3780-9.

9.

Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.

Sheu SY, Vogel E, Worm K, Grabellus F, Schwertheim S, Schmid KW.

Histopathology. 2010 Apr;56(5):632-40. doi: 10.1111/j.1365-2559.2010.03526.x.

PMID:
20459574
10.

Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.

Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5968-79.

11.

NATH, a novel gene overexpressed in papillary thyroid carcinomas.

Fluge Ø, Bruland O, Akslen LA, Varhaug JE, Lillehaug JR.

Oncogene. 2002 Aug 1;21(33):5056-68.

12.

Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC).

Breitkopf K, Roeyen Cv, Sawitza I, Wickert L, Floege J, Gressner AM.

Cytokine. 2005 Sep 7;31(5):349-57.

PMID:
16039137
13.

HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.

Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Zhang J.

Diagn Mol Pathol. 2011 Jun;20(2):71-80. doi: 10.1097/PDM.0b013e3181ed784d.

PMID:
21532495
14.

Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.

Murphy KM, Chen F, Clark DP.

Hum Pathol. 2008 Mar;39(3):420-6. doi: 10.1016/j.humpath.2007.07.015.

PMID:
18261626
15.

Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study.

Jin L, Seys AR, Zhang S, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Lloyd RV.

Diagn Mol Pathol. 2010 Jun;19(2):63-9. doi: 10.1097/PDM.0b013e3181b6a528.

PMID:
20502182
16.

Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.

Yang Z, Yuan Z, Fan Y, Deng X, Zheng Q.

Mol Med Rep. 2013 Nov;8(5):1353-8. doi: 10.3892/mmr.2013.1699. Epub 2013 Sep 24.

PMID:
24064622
18.

The expression and role of serum response factor in papillary carcinoma of the thyroid.

Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS.

Int J Oncol. 2009 Jul;35(1):49-55.

PMID:
19513551
20.

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

Supplemental Content

Support Center